103 related articles for article (PubMed ID: 7731676)
1. Androgen suppressed apoptosis is modified in p53 deficient mice.
Colombel M; Radvanyi F; Blanche M; Abbou C; Buttyan R; Donehower LA; Chopin D; Thiery JP
Oncogene; 1995 Apr; 10(7):1269-74. PubMed ID: 7731676
[TBL] [Abstract][Full Text] [Related]
2. Internucleosomal DNA fragmentation is not obligatory for castration induced rat ventral prostate cell apoptosis in vivo.
Zhang X; Decarli AJ; Buttyan R
Cell Death Differ; 1997 May; 4(4):304-10. PubMed ID: 16465245
[TBL] [Abstract][Full Text] [Related]
3. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model.
Zhao Y; Oberley TD; Chaiswing L; Lin SM; Epstein CJ; Huang TT; St Clair D
Oncogene; 2002 May; 21(24):3836-46. PubMed ID: 12032821
[TBL] [Abstract][Full Text] [Related]
4. Biomarker analysis demonstrates a hypoxic environment in the castrated rat ventral prostate gland.
Shabsigh A; Ghafar MA; de la Taille A; Burchardt M; Kaplan SA; Anastasiadis AG; Buttyan R
J Cell Biochem; 2001; 81(3):437-44. PubMed ID: 11255226
[TBL] [Abstract][Full Text] [Related]
5. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
Brändström A; Westin P; Bergh A; Cajander S; Damber JE
Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse with human mutant p53 expression in the prostate epithelium.
Elgavish A; Wood PA; Pinkert CA; Eltoum IE; Cartee T; Wilbanks J; Mentor-Marcel R; Tian L; Scroggins SE
Prostate; 2004 Sep; 61(1):26-34. PubMed ID: 15287091
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis during castration-induced regression of the prostate is Fos dependent.
Feng Z; Joos HJ; Vallan C; Mühlbauer R; Altermatt HJ; Jaggi R
Oncogene; 1998 Nov; 17(20):2593-600. PubMed ID: 9840922
[TBL] [Abstract][Full Text] [Related]
9. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
10. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of apoptotic activity following castration in human prostatic tissue in vivo.
Staack A; Kassis AP; Olshen A; Wang Y; Wu D; Carroll PR; Grossfeld GD; Cunha GR; Hayward SW
Prostate; 2003 Feb; 54(3):212-9. PubMed ID: 12518326
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation.
Merritt AJ; Allen TD; Potten CS; Hickman JA
Oncogene; 1997 Jun; 14(23):2759-66. PubMed ID: 9190891
[TBL] [Abstract][Full Text] [Related]
13. Influence of p53 zygosity on select sperm parameters of the mouse.
Marty MS; Singh NP; Holsapple MP; Gollapudi BB
Mutat Res; 1999 Jun; 427(1):39-45. PubMed ID: 10354500
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced apoptosis of human prostate cancer cells is independent of mutant p53 overexpression.
Kyprianou N; Rock S
Anticancer Res; 1998; 18(2A):897-905. PubMed ID: 9615738
[TBL] [Abstract][Full Text] [Related]
15. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation.
Clarke AR; Gledhill S; Hooper ML; Bird CC; Wyllie AH
Oncogene; 1994 Jun; 9(6):1767-73. PubMed ID: 8183575
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of rat ventral prostate after castration involves heparanase-1.
Augusto TM; Felisbino SL; Carvalho HF
Cell Tissue Res; 2008 May; 332(2):307-15. PubMed ID: 18278514
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
[TBL] [Abstract][Full Text] [Related]
18. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN
Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153
[TBL] [Abstract][Full Text] [Related]
19. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
20. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.
Asamoto M; Hokaiwado N; Cho YM; Takahashi S; Ikeda Y; Imaida K; Shirai T
Cancer Res; 2001 Jun; 61(12):4693-700. PubMed ID: 11406539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
